Prothena reported $2.9B in Market Capitalization this November of 2022, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US USD 2.65B 373M
Agios Pharmaceuticals AGIO:US USD 1.55B 335M
Akebia Therapeutics AKBA:US USD 58M 7M
ALKERMES ALKS:US USD 3.67B 1.23B
Alnylam Pharmaceuticals ALNY:US USD 24.62B 6.97B
Amgen AMGN:US USD 120.36B 9.61B
Biogen BIIB:US USD 39.1B 9.24B
Biomarin Pharmaceutical BMRN:US USD 15.72B 392M
Bluebird Bio BLUE:US USD 488M 192M
Exelixis EXEL:US USD 5.05B 1.63B
Intercept Pharmaceuticals ICPT:US USD 574M 164M
Intra Cellular Therapies ITCI:US USD 4.41B 977M
IONIS PHARMACEUT IONS:US USD 6.28B 1.03B
Macrogenics MGNX:US USD 213M 32M
Nektar Therapeutics NKTR:US USD 600M 108M
Neurocrine Biosciences NBIX:US USD 10.16B 841M
Prothena PRTA:US USD 2.84B 1.57B
Regeneron Pharmaceuticals REGN:US USD 75.09B 10.16B
Seattle Genetics SGEN:US USD 25.24B 7.33B
Ultragenyx Pharmaceutical RARE:US USD 2.9B 1.27B
Vertex Pharmaceuticals VRTX:US USD 74.3B 2.16B
Vital Therapies VTL:US USD 97M 21M
Xoma XOMA:US USD 205M 50M
YTE INCY:US USD 14.82B 2.01B